Braun L. Cohen M. Herbs Natural Supplements – An evidence-based guide. 4th Edition, Volume 2, Churchill Livingstone, Sydney, 2015, pp.865-870
Bagur MJ, Alonso Salinas GL, Jiménez-Monreal AM, Chaouqi S, Llorens S, Martínez-Tomé M et al. Saffron: An Old Medicinal Plant and a Potential Novel Functional Food. Molecules. (2017) Dec 23;23(1):30.
Leone S, Recinella L, Chiavaroli A, Orlando G, Ferrante C, Leporini L, Brunetti L, Menghini L et al. Phytotherapic use of the Crocus sativus L. (Saffron) and its potential applications: A brief overview. Phytotherapy Research. (2018) 32:2364–2375.
Tóth B, Hegyi P, Lantos T, Szakács Z, Kerémi B, Varga G, Tenk J, Pétervári E, Balaskó M, Rumbus Z, Rakonczay Z, Bálint ER, Kiss T, Csupor D. The Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Meta-analysis. Planta Med. (2019) Jan 85(1):24-31.
Sarris J et al. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. (2011) Dec;21(12):841-60
Hausenblas HA et al. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med. (2013) Nov;11(6):377- 83
Shahmansouri N et al. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. J Affect Disord 155 (2014):216-222
Akhondzadeh BA et al. Comparison of peta lof Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilor double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiartry 31.2 (2007):439-422
Noorbala AA et al. Hydro-alcoholic extract of Crocus sativus L. verses fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol 97.2 (2005):281-284
Sarris J. Herbal medicines in the treatment of psychiatric disorders: 10-year updated review. Phytotherapy Research. (2018):1–16
Anha-Hosseini M et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo controlled trial. BJPG 115.4 (2008): 515-519
Finley JW, Gao S. A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer’s Disease. J Agric Food Chem. (2017) Feb 8;65(5):1005-1020
Broadhead GK, Grigg JR, McCluskey P, Hong T, Schlub TE, Chang AA. Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial. Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):31-40.
Piccardi M, Fadda A, Martelli F, Marangoni D, Magli A, Minnella AM et al. Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy. Nutrients. 2019 Oct 15;11(10):2461.
Falsini B, Piccardi M, Minnella A, Savastano C, Capoluongo E, Fadda A et al. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6118-24.
Heitmar R, Brown J, Kyrou I. Saffron (Crocus sativus L.) in Ocular Diseases: A Narrative Review of the Existing Evidence from Clinical Studies. Nutrients. 2019 Mar; 11(3): 649.
Bostan HB, Mehri S, Hosseinzadeh H. Toxicology effects of saffron and its constituents: a review. Iran J Basic Med Sci. 2017 Feb;20(2):110-121.
